The incidence of cardiovascular diseases is lower in premenopausal women than in men of a similar age, and increases markedly after the menopause (1, 2). Estrogen replacement therapy is effective in protecting postmenopausal women from coronary heart disease (2-4). These epidemiological findings suggest that estrogen has an anti-atherogenic action. The mechanism, however, is not fully understood.
A number of investigators have reported that lipid metabolism contributes to the effects of estrogen (5, 6).
Estrogen increases serum high-density lipoprotein (HDL) cholesterol level and decreases serum low-density lipoprotein (LDL) cholesterol level. Also, direct actions of estrogen on the vascular wall have been reported. Estrogen has both endothelium-independent (7, 8) and endothelium-dependent (9-11) vasodilator actions, which may contribute to the inhibition of atherosclerosis. Estrogen-induced production of nitric oxide (NO) (12, 13) is considered to be a possible explanation for endotheliumdependent vasodilation and cardioprotection.
However, we can find no report investigating the anti-atherogenic effects of estrogen and estrogen-induced NO production in the same study.
The aim of this study was to examine the effects of estrogen replacement on atherosclerosis formation in ovariectomized cholesterol-fed rabbits, and to further examine serum levels of nitrite/nitrate (NOx), stable metabolites of NO, in order to investigate the involvement of NO in the effects of estrogen.
Materials and Methods
Animal experiments Eighteen female New Zealand White rabbits weighing about 3.0 kg each were purchased from the Saitama Animal Laboratory (Saitama). They were kept individually in stainless steel cages in a room maintained at 23°C. All surgical and experimental procedures were approved by the Animal Research Committee of the University of Tokyo.
The rabbits were bilaterally ovariectomized under pentobarbital anesthesia and 10,000 unit/kg penicillin G was administered intramuscularly. After a one-week recovery period, they were randomly divided into three groups : 1) normal diet (ND, n = 5), 2) 1% cholesterol diet (CD, n = 6), and 3) 1% cholesterol diet plus estrogen replacement (CD+ E, n =7). Estrogen was replaced by subcutaneous injection of 20 ,ug/kg estradiol dipropionate (Teikoku Hormone Co., Tokyo) once a week. Cholesterol was added to the normal diet (RC4, Oriental Yeast, Tokyo), which contained 3% fat. The calorie count was 294 kcal per 100 g. The rabbits were allowed free access to water. Each rabbit received 120 g daily of the assigned diet and was fed the whole diet every day of the experiment. posterior half of each aorta was used for the quantification of atherosclerosis as described previously (14, 17) . The aortas were attached to a plastic board and were fixed with 10% formalin buffer for 24h. The aortas were then washed with distilled water and stained by incubation in Oil red 0 solution for 20 min as described by Willis et al. (18) . After staining, the intimal surface was photographed. The area of the stained surface was measured with a digitizer connected to a Macintosh computer.
The ratio of the stained area to the whole surface of the posterior half of the aorta (% Oil red 0-positive area) was considered to be the magnitude of atherosclerosis.
Hearts were also excised and fixed with 10% formalin buffer for 24h. The left main coronary artery approximately 2 mm distal from the ostium was used for the evaluation of coronary atherosclerosis.
Three serial cross-sections at 0.5-mm intervals were prepared and stained by Elastica van Gieson staining. The area inside the internal elastic lamina (hypothetical luminal area) and the area of the intima were measured with a digitizer connected to a Macintosh computer.
The ratio of the intimal area to the hypothetical luminal area (% coronary artery stenosis) was calculated, and the mean of the three sections was considered to be the degree of coronary atherosclerosis of each animal. 
Measurement of serum NOx levels

Discussion
We showed that estrogen replacement to ovariectomized rabbits inhibited the cholesterol diet-induced atherosclerosis in both the aorta and the coronary artery without affecting serum lipid levels. The serum NOx levels were decreased by cholesterol feeding and there was a non-significant trend towards higher NOx levels after estrogen replacement.
We found a number of animal experiments in which estrogen inhibited atherosclerosis induced by a high cholesterol diet. Some experiments focused on the beneficial effects of estrogen on the lipid metabolism (21-23), and others pointed out additional mechanisms such as direct actions of estrogen on the vascular wall (24-26). Since estrogen replacement had no effect on the serum lipid levels, estrogen effects on atherosclerosis were independent of lipid metabolism in this study. Although it is unknown why estrogen administration did not affect the serum lipid levels in this study, several conditions related to the experiments may be the cause of the difference compared to the previous studies (21-23) : Kushwaha et al. (22) and Adams et al. (23) examined the effects of estrogen using monkeys, while we used rabbits. Kushwaha et al. (21) also reported that exogenous estrogen attenuated hypercholesterolemia in rabbits. However, in their study the rabbits were fed with a lower cholesterol diet (0.2%) and were injected with a higher dose of estrogen (500 mg/kg/wk) than in our study. Thus the lower cholesterol diet or the higher estrogen administration may affect serum lipid levels. It has been reported that estrogen inhibits LDL oxidation in vitro (27) and in vivo (28). These studies indicate that estrogen has an anti-oxidant action and may inhibit atherosclerosis. However, it is unlikely that estrogen inhibited the lipid peroxidation in this study because serum levels of TBARS, an index of lipoprotein oxidation, were not changed by estrogen replacement.
Although hypertension is reported to increase after menopause (29), the influence of estrogen administration on blood pressure is controvertial (30). In the present study, systolic blood pressure in the cholesterol diet group was significantly higher by c:55 mmHg than in the cholesterol diet plus estrogen replacement group at 3 months into the experiment.
Although the difference in blood pressure between the two groups was small, estrogen might have decreased blood pressure and influenced atherosclerosis.
In the present study, serum NOx levels were significantly decreased by cholesterol feeding and partially restored by estrogen replacement.
These results are consistent with previous studies (13, 31). Tanaka et al. (31) reported that plasma NOx levels were lower in hypercholesterolemic patients, and Rosselli et al. (13) reported that plasma NOx levels were increased by estrogen replacement therapy in postmenopausal women. Since NO is a labile substance, it is convenient to measure NOx as a marker of NO production (19, 20) . We collected blood after 16-hour fasting to exclude the influence of food intake on serum NOx levels (32, 33). Furthermore, as is shown in the methods, the accuracy of the assay was not influenced by high cholesterol concentration of the serum. This indicates that serum NOx levels reflected the endogenous production of NO. However, the origin of circulating NO is obscure because NO is synthesized not only in endothelial cells but also in other cells and tissues (34). It is known that NO inhibits atherosclerosis by regulating several factors, eg, cell adhesion (35) and smooth muscle cell proliferation (36). Thus, augmented production of NO by estrogen may affect atherosclerosis via these factors.
Other vascular effects unrelated to NO might be involved in the mechanism of atherogenesis.
FischerDzoga et al. (37) reported that estrogen inhibited the growth of cultured smooth muscle cells from rabbit aorta induced by hyperlipemic serum. Fischer et al. (38) reported that estrogen decreased collagen synthesis in atherosclerotic rabbit aortas. Consequently, it is possible that estrogen directly inhibited smooth muscle cell prolifera- tion and/or collagen synthesis although no direct evidence was shown in this study.
In conclusion, estrogen replacement inhibited atherosclerosis formation in cholesterol-fed ovariectomized rabbits. Direct actions on the vascular wall including NO production could contribute to the effects of estrogen. 
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